JP5224834B2 - Tablets containing processed plant products and panthetins - Google Patents
Tablets containing processed plant products and panthetins Download PDFInfo
- Publication number
- JP5224834B2 JP5224834B2 JP2008015688A JP2008015688A JP5224834B2 JP 5224834 B2 JP5224834 B2 JP 5224834B2 JP 2008015688 A JP2008015688 A JP 2008015688A JP 2008015688 A JP2008015688 A JP 2008015688A JP 5224834 B2 JP5224834 B2 JP 5224834B2
- Authority
- JP
- Japan
- Prior art keywords
- tablet
- pantethine
- pepper
- plant
- processed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000196324 Embryophyta Species 0.000 claims description 96
- DJWYOLJPSHDSAL-ROUUACIJSA-N pantethine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)[C@H](O)C(C)(C)CO DJWYOLJPSHDSAL-ROUUACIJSA-N 0.000 claims description 60
- 235000008975 pantethine Nutrition 0.000 claims description 44
- DJWYOLJPSHDSAL-UHFFFAOYSA-N Pantethine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCSSCCNC(=O)CCNC(=O)C(O)C(C)(C)CO DJWYOLJPSHDSAL-UHFFFAOYSA-N 0.000 claims description 42
- 239000011581 pantethine Substances 0.000 claims description 42
- 229960000903 pantethine Drugs 0.000 claims description 42
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical class OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 38
- 238000000034 method Methods 0.000 claims description 25
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Chemical class OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 21
- 239000011713 pantothenic acid Chemical class 0.000 claims description 19
- 235000019161 pantothenic acid Nutrition 0.000 claims description 19
- 229940055726 pantothenic acid Drugs 0.000 claims description 19
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 18
- ZNXZGRMVNNHPCA-UHFFFAOYSA-N Pantetheine Natural products OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS ZNXZGRMVNNHPCA-UHFFFAOYSA-N 0.000 claims description 18
- 229940101267 panthenol Drugs 0.000 claims description 18
- 235000020957 pantothenol Nutrition 0.000 claims description 18
- 239000011619 pantothenol Substances 0.000 claims description 18
- 241000736199 Paeonia Species 0.000 claims description 17
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 17
- 150000002948 pantothenic acids Chemical class 0.000 claims description 17
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 13
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 12
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 12
- 229940010454 licorice Drugs 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 235000002639 sodium chloride Nutrition 0.000 claims description 12
- 239000004480 active ingredient Substances 0.000 claims description 11
- 241000202807 Glycyrrhiza Species 0.000 claims description 8
- 244000273928 Zingiber officinale Species 0.000 claims description 7
- 235000006886 Zingiber officinale Nutrition 0.000 claims description 7
- 235000008397 ginger Nutrition 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 6
- 241000555712 Forsythia Species 0.000 claims description 5
- 239000010440 gypsum Substances 0.000 claims description 2
- 229910052602 gypsum Inorganic materials 0.000 claims description 2
- 238000012545 processing Methods 0.000 claims description 2
- 240000003421 Dianthus chinensis Species 0.000 claims 2
- 241000222336 Ganoderma Species 0.000 claims 2
- 241000756137 Hemerocallis Species 0.000 claims 2
- 241000238557 Decapoda Species 0.000 claims 1
- 235000006679 Mentha X verticillata Nutrition 0.000 claims 1
- 235000002899 Mentha suaveolens Nutrition 0.000 claims 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims 1
- 241000237536 Mytilus edulis Species 0.000 claims 1
- 235000020638 mussel Nutrition 0.000 claims 1
- ZNXZGRMVNNHPCA-VIFPVBQESA-N pantetheine Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCS ZNXZGRMVNNHPCA-VIFPVBQESA-N 0.000 claims 1
- 239000003826 tablet Substances 0.000 description 138
- 239000000047 product Substances 0.000 description 89
- 239000000284 extract Substances 0.000 description 28
- 238000002156 mixing Methods 0.000 description 21
- 230000000694 effects Effects 0.000 description 20
- 239000000843 powder Substances 0.000 description 20
- 230000006872 improvement Effects 0.000 description 13
- 239000000463 material Substances 0.000 description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 240000004371 Panax ginseng Species 0.000 description 10
- 235000008434 ginseng Nutrition 0.000 description 9
- 239000002994 raw material Substances 0.000 description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 description 8
- 229920002472 Starch Polymers 0.000 description 8
- 239000000419 plant extract Substances 0.000 description 8
- 235000019698 starch Nutrition 0.000 description 8
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 7
- -1 alkali metal salts Chemical class 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 239000008107 starch Substances 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 238000007796 conventional method Methods 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 5
- 244000303040 Glycyrrhiza glabra Species 0.000 description 5
- 229930195725 Mannitol Natural products 0.000 description 5
- 239000011230 binding agent Substances 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000000594 mannitol Substances 0.000 description 5
- 235000010355 mannitol Nutrition 0.000 description 5
- 238000004904 shortening Methods 0.000 description 5
- 235000010356 sorbitol Nutrition 0.000 description 5
- 239000000600 sorbitol Substances 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- 239000000845 maltitol Substances 0.000 description 4
- 235000010449 maltitol Nutrition 0.000 description 4
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 4
- 229940035436 maltitol Drugs 0.000 description 4
- 239000000546 pharmaceutical excipient Substances 0.000 description 4
- 238000001694 spray drying Methods 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 3
- 241000132011 Atractylodes lancea Species 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 3
- 235000002789 Panax ginseng Nutrition 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- VBICKXHEKHSIBG-UHFFFAOYSA-N beta-monoglyceryl stearate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- 238000013329 compounding Methods 0.000 description 3
- 239000007884 disintegrant Substances 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000008101 lactose Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 230000008569 process Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- 239000005995 Aluminium silicate Substances 0.000 description 2
- 241000544270 Angelica acutiloba Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 235000002566 Capsicum Nutrition 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 2
- 244000183685 Citrus aurantium Species 0.000 description 2
- 235000007716 Citrus aurantium Nutrition 0.000 description 2
- 235000000228 Citrus myrtifolia Nutrition 0.000 description 2
- 235000016646 Citrus taiwanica Nutrition 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 2
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 2
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 2
- 239000006002 Pepper Substances 0.000 description 2
- 235000016761 Piper aduncum Nutrition 0.000 description 2
- 235000017804 Piper guineense Nutrition 0.000 description 2
- 240000003889 Piper guineense Species 0.000 description 2
- 235000008184 Piper nigrum Nutrition 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 235000008632 Santalum album Nutrition 0.000 description 2
- 240000000513 Santalum album Species 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- XWCYDHJOKKGVHC-UHFFFAOYSA-N Vitamin A2 Chemical compound OCC=C(C)C=CC=C(C)C=CC1=C(C)C=CCC1(C)C XWCYDHJOKKGVHC-UHFFFAOYSA-N 0.000 description 2
- 229930003571 Vitamin B5 Natural products 0.000 description 2
- 239000003655 absorption accelerator Substances 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 235000012211 aluminium silicate Nutrition 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 235000006533 astragalus Nutrition 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 2
- 229960002079 calcium pantothenate Drugs 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000004088 foaming agent Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000314 lubricant Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000004570 mortar (masonry) Substances 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000009492 vitamin B5 Nutrition 0.000 description 2
- 239000011675 vitamin B5 Substances 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- KQQXUARABJGCMS-UHFFFAOYSA-N 3-methylbutyl 2-hydroxy-2-phenylacetate Chemical group CC(C)CCOC(=O)C(O)C1=CC=CC=C1 KQQXUARABJGCMS-UHFFFAOYSA-N 0.000 description 1
- QCQCHGYLTSGIGX-GHXANHINSA-N 4-[[(3ar,5ar,5br,7ar,9s,11ar,11br,13as)-5a,5b,8,8,11a-pentamethyl-3a-[(5-methylpyridine-3-carbonyl)amino]-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3h-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dimethyl-4-oxobutanoic acid Chemical compound N([C@@]12CC[C@@]3(C)[C@]4(C)CC[C@H]5C(C)(C)[C@@H](OC(=O)CC(C)(C)C(O)=O)CC[C@]5(C)[C@H]4CC[C@@H]3C1=C(C(C2)=O)C(C)C)C(=O)C1=CN=CC(C)=C1 QCQCHGYLTSGIGX-GHXANHINSA-N 0.000 description 1
- IJJWOSAXNHWBPR-HUBLWGQQSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-(6-hydrazinyl-6-oxohexyl)pentanamide Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCCCC(=O)NN)SC[C@@H]21 IJJWOSAXNHWBPR-HUBLWGQQSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000045403 Astragalus propinquus Species 0.000 description 1
- FBMORZZOJSDNRQ-GLQYFDAESA-N Atractylenolide III Chemical compound C=C([C@@H]1C2)CCC[C@]1(C)C[C@@]1(O)C2=C(C)C(=O)O1 FBMORZZOJSDNRQ-GLQYFDAESA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 241000336316 Cistanche tubulosa Species 0.000 description 1
- 241001561395 Citrus natsudaidai Species 0.000 description 1
- 241000533367 Cnidium officinale Species 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000723281 Ephedra equisetina Species 0.000 description 1
- 241000723237 Ephedra intermedia Species 0.000 description 1
- 241001465251 Ephedra sinica Species 0.000 description 1
- 241001198934 Forsythia viridissima Species 0.000 description 1
- 244000111489 Gardenia augusta Species 0.000 description 1
- 235000018958 Gardenia augusta Nutrition 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 229920001543 Laminarin Polymers 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- JEVVKJMRZMXFBT-XWDZUXABSA-N Lycophyll Natural products OC/C(=C/CC/C(=C\C=C\C(=C/C=C/C(=C\C=C\C=C(/C=C/C=C(\C=C\C=C(/CC/C=C(/CO)\C)\C)/C)\C)/C)\C)/C)/C JEVVKJMRZMXFBT-XWDZUXABSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 244000245214 Mentha canadensis Species 0.000 description 1
- 235000016278 Mentha canadensis Nutrition 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 1
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 description 1
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 241000286209 Phasianidae Species 0.000 description 1
- 241001127637 Plantago Species 0.000 description 1
- 244000274050 Platycodon grandiflorum Species 0.000 description 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 241000960945 Rheum coreanum Species 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000612118 Samolus valerandi Species 0.000 description 1
- 241001180873 Saposhnikovia divaricata Species 0.000 description 1
- 241000951376 Schizonepeta tenuifolia Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229920001800 Shellac Polymers 0.000 description 1
- 241001643409 Sinomenium acutum Species 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 238000010669 acid-base reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229960000913 crospovidone Drugs 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- 238000004042 decolorization Methods 0.000 description 1
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 description 1
- 238000004332 deodorization Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 239000004503 fine granule Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000001848 glycyrrhiza glabra l. root extract powder Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000007602 hot air drying Methods 0.000 description 1
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 229940071676 hydroxypropylcellulose Drugs 0.000 description 1
- 229960003943 hypromellose Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- DBTMGCOVALSLOR-VPNXCSTESA-N laminarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1O[C@@H]1[C@@H](O)C(O[C@H]2[C@@H]([C@@H](CO)OC(O)[C@@H]2O)O)O[C@H](CO)[C@H]1O DBTMGCOVALSLOR-VPNXCSTESA-N 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 238000005461 lubrication Methods 0.000 description 1
- 235000012661 lycopene Nutrition 0.000 description 1
- 229960004999 lycopene Drugs 0.000 description 1
- 239000001751 lycopene Substances 0.000 description 1
- OAIJSZIZWZSQBC-GYZMGTAESA-N lycopene Chemical compound CC(C)=CCC\C(C)=C\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C=C(/C)CCC=C(C)C OAIJSZIZWZSQBC-GYZMGTAESA-N 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229960003104 ornithine Drugs 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 238000011170 pharmaceutical development Methods 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000523 polyvinylpolypyrrolidone Polymers 0.000 description 1
- 235000013809 polyvinylpolypyrrolidone Nutrition 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 238000011403 purification operation Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 1
- 239000004208 shellac Substances 0.000 description 1
- 235000013874 shellac Nutrition 0.000 description 1
- 229940113147 shellac Drugs 0.000 description 1
- 235000020374 simple syrup Nutrition 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- ZCIHMQAPACOQHT-ZGMPDRQDSA-N trans-isorenieratene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/c1c(C)ccc(C)c1C)C=CC=C(/C)C=Cc2c(C)ccc(C)c2C ZCIHMQAPACOQHT-ZGMPDRQDSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Description
本発明は、所望の機械的強度および崩壊性を有する、植物加工物を含有する錠剤に関する。 The present invention relates to tablets containing processed plant products having the desired mechanical strength and disintegration.
一般に錠剤は、1個の計量単位として摂取し易く、服用が容易であり、その製法も比較的容易であるなどの理由から、多くの医薬品、健康食品等に利用されている。錠剤は、製錠された後、包装されて輸送されるが、この過程で相当の振動、衝撃等の外力を受けるので、その商品価値を維持するため、錠剤が崩壊しないように適当な機械的強度(硬度)を有するように製錠しなければならない。 In general, tablets are used in many pharmaceuticals, health foods, and the like because they are easy to ingest as one unit of measurement, easy to take, and relatively easy to produce. Tablets are packaged and then transported after being tableted. In this process, the tablet is subjected to considerable external forces such as vibration and impact. It must be tableted to have strength (hardness).
また一方で、内服薬などの場合、服用後一定時間で崩壊しなければ効果が発揮されない。このため、硬度を増加させるとともに、適度な崩壊性を錠剤に付与することが必要となる。 On the other hand, in the case of internal medicine or the like, the effect is not exhibited unless it is disintegrated within a certain time after taking. For this reason, it is necessary to increase hardness and to impart moderate disintegration to the tablet.
錠剤の硬度を増加させる手段の一つとして、打錠圧を増加することが知られている(非特許文献1)。しかしながら、植物抽出物を含有する錠剤の製造において、過剰な打錠圧は打錠時のキャッピング(錠剤上面の剥離)、ラミネーション(層状の剥離)等の原因となるので望ましくない。そればかりか、硬度を高めることで、崩壊性が低下してしまうという大きな問題が生じていた。 Increasing tableting pressure is known as one means for increasing the hardness of tablets (Non-patent Document 1). However, in the production of a tablet containing a plant extract, excessive tableting pressure is undesirable because it causes capping (peeling of the upper surface of the tablet), lamination (lamellar peeling), and the like during tableting. In addition to that, there is a big problem that the disintegration is lowered by increasing the hardness.
錠剤の崩壊性を向上させる手段として、(1)デンプンやセルロース類などの崩壊剤の添加、(2)酸塩基反応による発泡作用の利用(発泡剤の添加)、(3)滑沢剤の微量化(外部滑沢)が知られている(非特許文献2および3)。しかしながら、1錠あたりの原料の配合量が限られているので、“崩壊剤や発泡剤の添加”は、有効成分などの配合量を低下させてしまう点が、また、“滑沢剤の微量化”では得られる効果が小さいという点が問題であった。 As means for improving the disintegration of tablets, (1) Addition of disintegrants such as starch and cellulose, (2) Use of foaming action by acid-base reaction (addition of foaming agent), (3) Trace amount of lubricant (External lubrication) is known (Non-Patent Documents 2 and 3). However, since the blending amount of raw materials per tablet is limited, “addition of disintegrants and foaming agents” reduces the blending amount of active ingredients, etc. The problem was that the effect obtained with “Corporation” was small.
このため、錠剤の硬度を高めるとともに、崩壊性も向上できる方法が求められていた。
そこで、本発明は、機械的強度および崩壊性の点で優れた効果を有する植物加工物を含有する錠剤を提供することを目的とする。 Then, an object of this invention is to provide the tablet containing the plant processed material which has the effect excellent in the mechanical strength and the disintegration point.
本発明者は、植物加工物および錠剤を構成する他の全てまたは一部の材料を混合し、当該混合物を造粒して顆粒とし、その後、常法により打錠し、錠剤を製造した。また、本発明者は、錠剤を構成する全ての材料を混合し、その後、得られた混合物を常法により直接打錠し、錠剤を製造した。この場合、前者の造粒工程を経て製錠された錠剤は、造粒工程を経ることなく直接製錠された後者の錠剤と比較して硬度が高く、したがって製造方法を変更することで錠剤強度の改善が認められた。しかしながら、前記錠剤の場合であっても、商品として流通に耐え得る錠剤としては、なお不充分であった。 The inventor mixed all or part of the plant processed product and other ingredients constituting the tablet, granulated the mixture into granules, and then compressed the tablet by a conventional method to produce a tablet. In addition, the inventor mixed all the materials constituting the tablet, and then directly tableted the obtained mixture by a conventional method to produce a tablet. In this case, the tablet that was tableted through the former granulation process has higher hardness than the latter tablet that was directly tableted without going through the granulation process, and therefore the tablet strength can be changed by changing the manufacturing method. Improvement was observed. However, even in the case of the tablet, it is still insufficient as a tablet that can endure distribution as a commercial product.
また、本発明者は、植物加工物に公知の賦形剤であるコーンスターチなどのデンプン類、乳糖、ショ糖などの糖類、でん粉のりやヒドロキシプロピルセルロースなどの結合剤を添加し、従来の方法により錠剤の製造を多数試みた。しかしながら、この場合も硬度および崩壊性の点で満足のいくものではなかった。 In addition, the present inventors added starches such as corn starch, which are known excipients to plant processed products, saccharides such as lactose and sucrose, binders such as starch paste and hydroxypropylcellulose, and the like. Many attempts were made to produce tablets. However, even in this case, the hardness and disintegration were not satisfactory.
本発明者は、上記課題に鑑み鋭意研究を重ねたところ、植物加工物とパンテチン類とを併用することによって、植物加工物を含有する錠剤の硬度が向上され、かつ崩壊時間が短縮された錠剤が得られることを見出した。すなわち、パンテチン類には、植物加工物を含有する錠剤の硬度を向上させ、かつ崩壊時間を短縮できる効果があると考えられる。本発明は上記知見に基づきさらに検討を重ねた結果完成されたものであり、下記に掲げるものである。
(1)錠剤
(1−1)植物加工物ならびにパンテチン、パンテチンの塩、パントテン酸、パントテン酸の塩、パンテテインおよびパンテノールから選択される少なくとも1種のパンテチン類を含有する錠剤。
(1−2) 植物加工物が、ダイオウ、カンゾウ、マオウ、シャクヤク、オウゴンおよびショウキョウからなる群から選択される少なくとも1種を含む植物加工物である、上記(1−1)に記載の錠剤。
(1−3) 錠剤の垂直方向の硬度が6N以上である、上記(1−1)または(1−2)に記載の錠剤。
(2)硬度向上剤、崩壊性向上剤
(2−1)パンテチン、パンテチンの塩、パントテン酸、パントテン酸の塩、パンテテインおよびパンテノールから選択される少なくとも1種のパンテチン類を有効成分とする、植物加工物を含有する錠剤の硬度向上剤。
(2−2)パンテチン、パンテチンの塩、パントテン酸、パントテン酸の塩、パンテテインおよびパンテノールから選択される少なくとも1種のパンテチン類を有効成分とする、植物加工物を含有する錠剤の崩壊性向上剤。
(2−3)パンテチン、パンテチンの塩、パントテン酸、パントテン酸の塩、パンテテインおよびパンテノールから選択される少なくとも1種のパンテチン類を有効成分とする、植物加工物を含有する錠剤の硬度及び崩壊性向上剤。
(3)硬度向上方法、崩壊性向上方法
(3−1)植物加工物と、パンテチン、パンテチンの塩、パントテン酸、パントテン酸の塩、パンテテインおよびパンテノールから選択される少なくとも1種のパンテチン類とを併用する、植物加工物を含有する錠剤の硬度向上方法。
(3−2)植物加工物と、パンテチン、パンテチンの塩、パントテン酸、パントテン酸の塩、パンテテインおよびパンテノールから選択される少なくとも1種のパンテチン類とを併用する、植物加工物を含有する錠剤の崩壊性向上方法。
(3−3)植物加工物と、パンテチン、パンテチンの塩、パントテン酸、パントテン酸の塩、パンテテインおよびパンテノールから選択される少なくとも1種のパンテチン類とを併用する、植物加工物を含有する錠剤の硬度及び崩壊性向上方法。
The present inventor has made extensive studies in view of the above problems, and as a result, the hardness of the tablet containing the plant processed product is improved and the disintegration time is shortened by using the plant processed product and panthetin together. It was found that can be obtained. In other words, panthetins are considered to have the effect of improving the hardness of tablets containing processed plant products and shortening the disintegration time. The present invention has been completed as a result of further studies based on the above findings, and is described below.
(1) Tablet (1-1 ) A tablet containing a plant product and at least one panthetin selected from pantethine, pantethine salt, pantothenic acid, pantothenic acid salt, pantethein and panthenol.
(1-2) The tablet according to (1-1) above, wherein the plant processed product is a plant processed product containing at least one selected from the group consisting of Daio, Licorice, Mao, Peonies, Ogon, and Ginger. .
(1-3) The tablet according to (1-1) or (1-2) above, wherein the tablet has a vertical hardness of 6N or more.
(2) Hardness improver, disintegration improver (2-1) pantethine, pantethine salt, pantothenic acid, pantothenic acid salt, pantethein and panthenol as an active ingredient, Hardness improver for tablets containing processed plant products.
(2-2) Improvement of disintegration of tablets containing plant processed products containing at least one type of pantethine selected from pantethine, pantethine salt, pantothenic acid, pantothenic acid salt, pantethein and panthenol as an active ingredient Agent.
(2-3) Hardness and disintegration of tablets containing plant processed products containing as an active ingredient at least one pantethine selected from pantethine, pantethine salt, pantothenic acid, pantothenic acid salt, pantethein and panthenol Improver.
(3) Hardness improving method, disintegrating improving method (3-1) Plant processed product, and at least one pantethine selected from pantethine, pantethine salt, pantothenic acid, pantothenic acid salt, pantethein and panthenol A method for improving the hardness of a tablet containing a processed plant product.
(3-2) A tablet containing a processed plant product, wherein the processed plant product is used in combination with pantethine, a pantethine salt, pantothenic acid, a pantothenic acid salt, pantethein and panthenol. To improve the disintegration of
(3-3) A tablet containing a plant processed product, which is used in combination with a plant processed product and at least one panthetin selected from pantethine, pantethine salt, pantothenic acid, pantothenic acid salt, pantethein and panthenol Hardness and disintegration improvement method.
本発明の錠剤は、製錠されてから服用するまでに受ける振動や衝撃などの外力に十分に耐えることが可能な機械的強度を有する。また本発明の錠剤は、服用後一定時間で崩壊する適度な崩壊性を有する。 The tablet of the present invention has a mechanical strength that can sufficiently withstand external forces such as vibrations and impacts received from tableting to taking. Moreover, the tablet of this invention has moderate disintegration which disintegrates in a fixed time after taking.
また、本発明の錠剤によれば、配合される植物加工物およびパンテチン類に基づいて、その植物加工物特有の効能、およびパンテチン類由来のコレステロールに対する効果や腸の蠕動運動を活発化させる効果を、同時に得ることができる。 In addition, according to the tablet of the present invention, based on the plant processed product and panthetin to be blended, the effect unique to the plant processed product, the effect on the cholesterol derived from the panthetin and the effect of activating the peristaltic movement of the intestine Can be obtained at the same time.
また、パンテチン類を有効成分とする本発明の硬度および/または崩壊性向上剤によれば、植物加工物を含有する錠剤において、その機械的強度を高くでき、また崩壊時間を短縮させることができる。 In addition, according to the hardness and / or disintegration improver of the present invention containing pantethine as an active ingredient, the mechanical strength can be increased and the disintegration time can be shortened in tablets containing processed plant products. .
また、本発明の硬度および/または崩壊性向上方法によれば、植物加工物を含有する錠剤においてその機械的強度を高くでき、また崩壊時間を短縮させることができ、所望の効果を有する錠剤を得ることができる。 In addition, according to the method for improving hardness and / or disintegration of the present invention, a tablet containing a processed plant product can have high mechanical strength, can shorten disintegration time, and has a desired effect. Can be obtained.
本発明の錠剤は、植物加工物およびパンテチン類を含有することを主な特徴とする。以下、本発明の構成について詳細に説明する。
(1)植物加工物
本発明の錠剤に使用される植物加工物の原料は限定されないが、例えば植物抽出物の原料として、朝鮮人参(Panax Ginseng)、田七人参(Panax pseudo-ginseng)、西洋人参(Panax quinquefolium Linne)、カンカ(Cistanche Tubulosa)プランタゴオバタ(Plantago. Ovata Forsk)マオウ(Ephedra sinica Stapf,Ephedra intermedia Schrenk et C.A. Meyer,Ephedra equisetina Bunge)、ダイオウ(Rheum palmatum Linne, Rheum tanguticum Maximowicz, Rheum officinable Baillon, Rheum coreanum Nakaiまたはそれらの種間雑種)、カンゾウ(Glycyrrhiza uralensis Fischer,Glycyrrhiza glabra Linne)、マオウ(Ephedra sinica Stapf,Ephedra intermedia Schrenk et C.A. Meyer,Ephedra equisetina Bunge)、シャクヤク(Paeonia lactiflora Pallas)、オウゴン(Scutellariae baicalensis Georgi)、ショウキョウ(Zingiber officinale Roscoe)、ケイガイ(Schizonepeta tenuifolia Briquet)、レンギョウ(Forsythia suspense Vahl, Forsythia viridissima Lindley)、トウキ(Angelica acutiloba Kitagawa, Angelica acutiloba Kitagawa var. sugiyamae Hikino)、センキュウ(Cnidium officinale Makino)、サンシン(Gardenia jasminoides Ellis)、ハッカ(Mentha arvensis Linne var. piperascens Malinvaud)、ボウフウ(Saposhnikovia divaricata Schischkin)、ビャクジュツ(Atractylodes japonica Koidzumi ex Kitamura, Atractylodes ovata De Candolle)、キキョウ(Platycodon grandiflorum A. De Candolle)、サイコ(Bupleurum falcatum Linne)、ハンゲ(Pinellia ternata Breitenbach)、タイソウ(Zizypus jujube Miller var. inermis Rehder)、キジツ(Citrus aurantium Linne var. daidai Makino, Citrus aurantium Linne ,Citrus natsudaidai Hayata)、ボウイ(Sinomenium acutum Rehder et Wilson)、オウギ(Astragalus membranaceus Bunge, Astragalus mongholicus Bunge)、ソウジュツ(Atractylodes lancea De Candolle, Atractylodeschinensis Koidzumi)等の植物が例示される。本発明の錠剤に使用される植物加工物は、その原料として、好ましくはダイオウ、カンゾウ、マオウ、シャクヤク、オウゴンおよびショウキョウからなる群から選択される少なくとも1種を含むことが好ましい。
The tablet of the present invention is mainly characterized by containing a processed plant product and panthetins. Hereinafter, the configuration of the present invention will be described in detail.
(1) Plant processed product The raw material of the plant processed product used in the tablet of the present invention is not limited. For example, as a raw material for plant extract, Panax Ginseng, Panax pseudo-ginseng, Western Carrot (Panax quinquefolium Linne), Kanka (Cistanche Tubulosa) Plantago. Ovata Forsk Baillon, Rheum coreanum Nakai or interspecific hybrids), licorice (Glycyrrhiza uralensis Fischer, Glycyrrhiza glabra Linne), maou (Ephedra sinica Stapf, Ephedra intermedia Schrenk et CA Meyer, Ephedra equisetina Bunge), peonies (Peonia lactiflor) (Scutellariae baicalensis Georgi), Zingiber officinale Roscoe, Schizonepeta tenuifolia Briqu et), Forsythia suspense Vahl, Forsythia viridissima Lindley, Toki (Angelica acutiloba Kitagawa, Angelica acutiloba Kitagawa var. sugiyamae Hikino), Senkyu (Cnidium officinale Makino), Sanshin (Gardenia jasminoides Ellis. piperascens Malinvaud), Bowfish (Saposhnikovia divaricata Schischkin), Sandalwood (Atractylodes japonica Koidzumi ex Kitamura, Atractylodes ovata De Candolle), Pepper (Platycodon grandiflorum A. De Candolle), Psycho (Bupleuin bach) (Zizypus jujube Miller var. Inermis Rehder), pheasant (Citrus aurantium Linne var. Daidai Makino, Citrus aurantium Linne, Citrus natsudaidai Hayata), bowie (Sinomenium acutum Rehder et Wilson), ogi (Astragalus membranaceus m (Atractylodes lancea De Candolle, Atractyl plant such as odeschinensis Koidzumi). The processed plant product used in the tablet of the present invention preferably contains at least one selected from the group consisting of Daio, Licorice, Mao, Peonies, Ogon, and Ginger as its raw material.
本発明において植物加工物とは、上記原料となる植物の粉砕物、乾燥物、溶媒抽出物等が挙げられる。使用する各植物の部位は、これらの植物から得られる加工物が本発明の所望の効果を奏する限り、特に限定されず、また、植物の種類によって適宜選択され得るが、例えば全草、根茎、葉、根、果実等が挙げられる。 In the present invention, the processed plant product includes a pulverized product, a dried product, a solvent extract and the like as the raw material. The site of each plant to be used is not particularly limited as long as the processed product obtained from these plants has the desired effect of the present invention, and can be appropriately selected depending on the type of plant, for example, whole plant, rhizome, Examples include leaves, roots and fruits.
上記植物の粉砕物は、ジェットミル等の当該分野で公知の粉砕器により上記植物を粉砕したものであれば特に限定されない。 The pulverized product of the plant is not particularly limited as long as the plant is pulverized by a pulverizer known in the art such as a jet mill.
乾燥物は、上記植物を生のまま乾燥させたものであれば特に限定されず、天日乾燥、遠赤外線照射、乾燥機(熱風乾燥、冷風乾燥、真空凍結乾燥)等の従来公知の方法に従って得ることができる。また、乾燥物中の水分量としては、10重量%以下が好ましく、8重量%以下がより好ましい。本発明において乾燥物の形態は問わず、植物体そのものの乾燥物、乾燥物の粉砕物等のいずれでもよい。乾燥粉砕物の場合であれば、上記粉砕物と同様の方法に従って得ることができる。また、本発明においては乾燥物として、原料となる植物体(好ましくは特に根茎部)を発酵処理や酵素処理した後乾燥して得られたものを使用することもできる。 The dried product is not particularly limited as long as the plant is dried as it is. According to a conventionally known method such as sun drying, far-infrared irradiation, dryer (hot air drying, cold air drying, vacuum freeze drying) and the like. Can be obtained. The water content in the dried product is preferably 10% by weight or less, and more preferably 8% by weight or less. In the present invention, the form of the dried product is not limited, and any of a dried product of the plant itself and a pulverized product of the dried product may be used. In the case of a dry pulverized product, it can be obtained according to the same method as the pulverized product. Moreover, in this invention, what was obtained by drying after making the plant body (preferably especially rhizome part) used as a raw material into a dried material after fermentation treatment or an enzyme treatment can also be used.
溶媒抽出物を得る方法は、例えば、上記植物、またはこれらの乾燥物、粉砕物等を水、熱水、有機溶媒(エタノール、メタノール、イソプロパノール、プロピレングリコール、1,3−ブチレングリコール等のアルコール;含水エタノール、含水メタノール等の含水アルコール;エーテル、ヘキサン、ベンゼン、クロロホルム、アセトン、ペンタン、酢酸エチル等)等またはこれらの混合物で抽出し、濾過する方法等が挙げられる。抽出の条件としては、一般的に植物抽出に適用されるものであれば特に限定されないが、例えば、乾燥物1重量部に対して、1〜500重量部、好ましくは10〜200重量部の水や有機溶媒を加え、室温〜100℃程度、好ましくは30〜70℃程度で撹拌しながら1〜300分程度、好ましくは30〜200分程度抽出を行った後、濾過により固形分を取り除く方法が挙げられる。また、「一般用漢方処方の手引き」(厚生省薬務局監修、日薬連漢方専門委員会編集、薬業時報社発行)に記載の漢方薬を得るための常法を用いることもできる。 The method for obtaining the solvent extract is, for example, the above-mentioned plant, or a dried product or pulverized product thereof with water, hot water, an organic solvent (alcohol such as ethanol, methanol, isopropanol, propylene glycol, 1,3-butylene glycol; Water-containing alcohols such as water-containing ethanol and water-containing methanol; ether, hexane, benzene, chloroform, acetone, pentane, ethyl acetate and the like) or a mixture thereof, and a method of filtering. The extraction conditions are not particularly limited as long as they are generally applied to plant extraction. For example, 1 to 500 parts by weight, preferably 10 to 200 parts by weight of water with respect to 1 part by weight of the dried product. Or an organic solvent, and after stirring for about 1 to 300 minutes, preferably about 30 to 200 minutes with stirring at room temperature to about 100 ° C., preferably about 30 to 70 ° C., the solid content is removed by filtration. Can be mentioned. Ordinary methods for obtaining herbal medicines described in "Guide for general-purpose Kampo prescriptions" (supervised by the Pharmaceutical Affairs Bureau of the Ministry of Health and Welfare, edited by the National Pharmacopoeia Special Committee, published by Yakuho Hokpo)
このようにして得られた溶媒抽出物は上記植物の可溶性成分が抽出溶媒に溶解した液状物である。 The solvent extract thus obtained is a liquid material in which the soluble components of the plant are dissolved in the extraction solvent.
この液状の抽出物は、必要に応じて濃縮してもよい。濃縮の方法としては、エバポレーター等の常法を用いることができる。また、本発明において液状の抽出物を粉末化する方法としては、例えば、得られた溶媒抽出物にデキストリン等の賦形剤を加え、スプレードライ等の当該分野で公知の方法に従って乾燥することができる。さらに、それぞれの原料となる植物由来の効果等が失われない範囲で脱臭、脱色等の精製操作を加えることもできる。 This liquid extract may be concentrated as necessary. As a concentration method, a conventional method such as an evaporator can be used. In addition, as a method of pulverizing the liquid extract in the present invention, for example, an excipient such as dextrin is added to the obtained solvent extract and dried according to a method known in the art such as spray drying. it can. Furthermore, purification operations such as deodorization and decolorization can be added as long as the effects derived from the plants that are the raw materials are not lost.
上記植物加工物は、2種類以上の原料植物をあらかじめ混合してから得ることもできる。 The plant processed product can also be obtained after mixing two or more kinds of raw material plants in advance.
本発明において用いる植物加工物は、本発明の効果が損なわれない限り特に限定されないが、各原料の溶媒抽出物の粉末形態を用いることが好ましい。簡便には、商業的に入手することができる植物加工物を使用することもできる。植物加工物は1種単独で用いてもよいが2種以上を組み合わせて用いることもできる。 The plant processed product used in the present invention is not particularly limited as long as the effects of the present invention are not impaired, but it is preferable to use a powder form of the solvent extract of each raw material. Conveniently, processed plant products that are commercially available can also be used. Processed plant products may be used alone or in combination of two or more.
本発明の錠剤における植物加工物の配合割合は、本発明の効果を奏する限り特に限定されないが、錠剤中に、植物加工物の乾燥重量総量で、通常0.1〜98重量%程度、好ましくは1〜95重量%程度、より好ましくは3〜90重量%程度、さらに好ましくは10〜90重量%程度、とくに好ましくは30〜80重量%程度が例示される。ここで、植物加工物として植物の抽出物が使用される場合には、得られた抽出物の乾燥重量を表す。 The blending ratio of the processed plant product in the tablet of the present invention is not particularly limited as long as the effects of the present invention are exhibited, but the total dry weight of the processed plant product in the tablet is usually about 0.1 to 98% by weight, preferably Examples include about 1 to 95% by weight, more preferably about 3 to 90% by weight, still more preferably about 10 to 90% by weight, and particularly preferably about 30 to 80% by weight. Here, when a plant extract is used as the processed plant product, it represents the dry weight of the obtained extract.
また、植物加工物としてダイオウ、カンゾウ、マオウ、シャクヤク、オウゴンおよび/またはショウキョウを使用する場合には、その配合量は、植物加工物の乾燥重量で、錠剤中に、通常0.001〜98重量%程度、より好ましくは0.01〜95重量%程度、さらに好ましくは0.03〜90重量%程度、さらに好ましくは0.1〜90重量%程度、とくに好ましくは0.3〜80重量%程度が例示される。
(2)パンテチン類
本発明の錠剤は、上記植物加工物とパンテチン類とを含有することを特徴とする。
Further, in the case of using daioh, licorice, mao, peony, ogon and / or shoyu as the processed plant product, the blending amount is the dry weight of the processed plant product, usually 0.001 to 98 in the tablet. % By weight, more preferably about 0.01 to 95% by weight, more preferably about 0.03 to 90% by weight, still more preferably about 0.1 to 90% by weight, and particularly preferably 0.3 to 80% by weight. The degree is exemplified.
(2) Panthetins The tablet of the present invention is characterized by containing the above processed plant product and panthetins.
本発明においてパンテチン類としては、パンテチン、ペンテチンの塩、パントテン酸、パンテテイン、パンテノール、およびパントテン酸の塩からなる群から選択される少なくとも1種が挙げられる。パンテチン塩またはパントテン酸の塩としては、薬学的に許容されるものであれば限定されず、例えばナトリウム塩、カリウム塩などのアルカリ金属塩、カルシウム塩、マグネシウム塩などのアルカリ土類金属、塩酸塩、硝酸塩、硫酸塩等の鉱酸塩、酢酸塩、クエン酸塩、安息香酸などの有機酸塩などを挙げることができる。これらのパンテチン類は類似の基本骨格を有している。 In the present invention, the pantethine includes at least one selected from the group consisting of pantethine, pentetine salt, pantothenic acid, pantethein, panthenol, and pantothenic acid salt. The pantethine salt or pantothenic acid salt is not limited as long as it is pharmaceutically acceptable. For example, alkali metal salts such as sodium salt and potassium salt, alkaline earth metals such as calcium salt and magnesium salt, and hydrochloride salt And mineral acid salts such as nitrate and sulfate, and organic acid salts such as acetate, citrate and benzoic acid. These panthetins have a similar basic skeleton.
本発明の錠剤には、パンテチン類の中から選択された1種単独でまたは2種以上を組み合わせて配合される。本発明の錠剤に配合されるパンテチン類としては、パンテチンが好ましい。 The tablet of the present invention is blended alone or in combination of two or more selected from pantetins. As pantethine compounded in the tablet of the present invention, pantethine is preferable.
パンテチン(Pantethine)は、ビス(2−{3−[(2R)−2,4−ジヒドロキシ−3,3−ジメチルブタノイルアミノ]プロパノイルアミノ}エチル)ジスルフィドとして表され、パントテン酸(ビタミンB5)誘導体または活性型ビタミンB5とも呼ばれる。 Panthethine is represented as bis (2- {3-[(2R) -2,4-dihydroxy-3,3-dimethylbutanoylamino] propanoylamino} ethyl) disulfide, and pantothenic acid (vitamin B5) Also called derivatives or active vitamin B5.
パンテチンは公知の化合物であり、従来公知の方法に従って合成することもできるが、パンテチンとしては例えばパンテチンA(第一三共プロファーマ製)等の商品も知られており、商業的に入手することもできる。パンテチン以外のパンテチン類も公知であり、従来の方法に従って得ることができ、また市販のものを用いることもできる。 Pantethine is a known compound, and can be synthesized according to a conventionally known method. However, as pantethine, for example, a product such as pantethine A (Daiichi Sankyo Propharma) is also known and must be obtained commercially. You can also. Panthetins other than pantethine are also known and can be obtained according to conventional methods, and commercially available products can also be used.
本発明の錠剤においてパンテチン類の配合割合は、本発明の効果を奏する限り特に限定されないが、通常、パンテチン量換算で0.01〜95重量%程度、好ましくは0.1〜80重量%程度、より好ましくは0.1〜40重量%程度である。 In the tablet of the present invention, the blending ratio of panthetins is not particularly limited as long as the effects of the present invention are exhibited, but is usually about 0.01 to 95% by weight, preferably about 0.1 to 80% by weight in terms of pantethine, More preferably, it is about 0.1 to 40% by weight.
パンテチン類として、とくにパンテチンを用いる場合は、その配合割合は錠剤中に、通常、総量で0.01〜95重量%程度、好ましくは0.1〜80重量%程度、より好ましくは0.1〜40重量%程度である。
(3)植物加工物に対するパンテチン類の配合割合
本発明の錠剤における、植物加工物に対するパンテチン類の配合割合は、本発明の効果を奏する限り特に限定されないが、植物加工物とパンテチン類の混合物が過剰にべたつくことなく、例えば、打錠時に使用する杵や臼に混合物が付着することなく、吸湿性も低い錠剤を好適に製造でき、また、パンテチン類由来のコレステロールに対する効果や腸の蠕動運動を活発化させる効果などが損なわれず、かつ硬度および崩壊性の点で優れた錠剤が製造できることから、例えば、植物加工物の総量100重量部に対するパンテチン類の総量の下限値は、好ましくは0.01重量部であり、より好ましくは0.1重量部であり、さらに好ましくは0.125重量部であり、とくに好ましくは0.2重量部である。また、パンテチン類の総量の上限値は、好ましくは30重量部であり、より好ましくは28重量部であり、さらに好ましくは25重量部である。ここで、前述のように、植物加工物として植物の抽出物が使用される場合には、上記配合量は得られた抽出物の乾燥重量を表す。
In particular, when pantethine is used as the panthetin, the blending ratio thereof is usually about 0.01 to 95% by weight, preferably about 0.1 to 80% by weight, more preferably about 0.1 to 80% by weight in the tablet. About 40% by weight.
(3) Blending ratio of pantethines to processed plant product The blending ratio of panthetins to plant processed product in the tablet of the present invention is not particularly limited as long as the effect of the present invention is exhibited. Without excessive stickiness, for example, a tablet with low hygroscopicity can be suitably manufactured without adhering the mixture to the pestle or mortar used for tableting, and it also has an effect on panthetin-derived cholesterol and intestinal peristalsis. For example, the lower limit of the total amount of panthetins with respect to 100 parts by weight of the total amount of processed plant products is preferably 0.01, since the effect of activating and the like is not impaired and a tablet excellent in hardness and disintegration can be produced. Parts by weight, more preferably 0.1 parts by weight, still more preferably 0.125 parts by weight, particularly preferably 0.2 parts by weight. It is the amount part. Moreover, the upper limit of the total amount of panthetins is preferably 30 parts by weight, more preferably 28 parts by weight, and even more preferably 25 parts by weight. Here, as described above, when a plant extract is used as the processed plant product, the blending amount represents the dry weight of the obtained extract.
植物加工物としては、ダイオウ、カンゾウ、マオウ、シャクヤク、オウゴンおよびショウキョウからなる群から選択される少なくとも1種を含むことが好ましい。この場合、ダイオウ、カンゾウ、マオウ、シャクヤク、オウゴンおよび/またはショウキョウの、全植物加工物量における配合割合は、3重量%以上が好ましく、5重量%以上がより好ましく、7重量%以上がさらに好ましい。
(4)錠剤の大きさ
本発明の錠剤の大きさは本発明の効果を奏する限りとくに限定されないが、使用対象、使用目的等に応じて適宜調整される。例えば、本発明の錠剤の直径は服用しやすいサイズが例示され、好ましくは直径18mm以下、より好ましくは15mm以下、さらに好ましくは12mm以下が例示される。また、本発明の錠剤の厚みも服用しやすいサイズが例示され、好ましくは直径10mm以下、より好ましくは9mm以下、さらに好ましくは8mm以下が例示される。
(5)錠剤に含有可能なほかの成分
本発明の錠剤には、例えば、担体として当該分野で従来公知のものを広く使用することができる。このような担体としては、例えば乳糖、白糖、塩化ナトリウム、ブドウ糖、尿素、デンプン、炭酸カルシウム、カオリン、ケイ酸等の賦形剤;水、エタノール、プロパノール、単シロップ、ブドウ糖液、デンプン液、ゼラチン溶液、カルボキシメチルセルロース、セラック、メチルセルロース、リン酸カリウム、ポリビニルピロリドン、結晶セルロース、ヒドロキシプロピルセルロース、ヒプロメロース、アルギン酸ナトリウム等の結合剤;乾燥デンプン、カンテン末、ラミナラン末、炭酸水素ナトリウム、ポリオキシエチレンソルビタン脂肪酸エステル類、ラウリル硫酸ナトリウム、ステアリン酸モノグリセリド、デンプン、クロスポビドン、ポビドン、低置換度ヒドロキシプロピルセルロース、等の崩壊剤;ステアリン、カカオバター、水素添加油等の崩壊抑制剤;第4級アンモニウム塩、ラウリル硫酸ナトリウム等の吸収促進剤;グリセリン等保湿剤;デンプン、乳糖、カオリン、ベントナイト、コロイド状ケイ酸等の吸着剤;精製タルク、ステアリン酸塩、ホウ酸末、ポリエチレングリコール等の滑沢剤等を使用できる。また、本発明の錠剤には、上記以外に、添加剤として、例えば界面活性剤、吸収促進剤、吸着剤、充填剤、防腐剤、安定剤、乳化剤、可溶化剤、浸透圧を調節する塩を含有させることができる。さらに、本発明の錠剤には、上記以外にアミノ酸、ビタミン類、有機酸塩類等の他の活性成分を含有させることができる。他の活性成分としては、例えば、バリン、ロイシン、イソロイシン、トレオニン、メチオニン、フェニルアラニン、トリプトファン、リジン、グリシン、アラニン、アスパラギン、グルタミン、セリン、システイン、シスチン、チロシン、プロリン、ヒドロキシプロリン、アスパラギン酸、グルタミン酸、ヒドロキシリジン、アルギニン、オルニチン、ヒスチジン等のアミノ酸;ビタミンA1、ビタミンA2、カロチン、リコピン(プロビタミンA)、ビタミンB6、ビタミンB1、ビタミンB2、アスコルビン酸、ニコチン酸アミド、ビオチン等のビタミン類;塩化ナトリウム、塩化カリウム等のアルカリ金属塩や、クエン酸塩、酢酸塩、リン酸塩等の有機酸塩類が例示される。
The processed plant product preferably contains at least one selected from the group consisting of daisou, licorice, mao, peony, oxon and ginger. In this case, the blending ratio in the total amount of processed plant of Daio, Licorice, Mao, Peonies, Ogon and / or Pepper is preferably 3% by weight or more, more preferably 5% by weight or more, and further preferably 7% by weight or more. .
(4) Size of tablet The size of the tablet of the present invention is not particularly limited as long as the effect of the present invention is exhibited, but is appropriately adjusted according to the use object, purpose of use and the like. For example, the size of the tablet of the present invention is exemplified by a size that is easy to take, preferably 18 mm or less, more preferably 15 mm or less, and even more preferably 12 mm or less. Further, the size of the tablet of the present invention is exemplified by a size that can be easily taken, preferably 10 mm or less in diameter, more preferably 9 mm or less, and still more preferably 8 mm or less.
(5) Other components that can be contained in tablets For the tablets of the present invention, for example, those conventionally known in the art can be widely used as carriers. Examples of such carriers include excipients such as lactose, sucrose, sodium chloride, glucose, urea, starch, calcium carbonate, kaolin, and silicic acid; water, ethanol, propanol, simple syrup, glucose solution, starch solution, gelatin Binders such as solution, carboxymethylcellulose, shellac, methylcellulose, potassium phosphate, polyvinylpyrrolidone, crystalline cellulose, hydroxypropylcellulose, hypromellose, sodium alginate; dry starch, agar powder, laminaran powder, sodium bicarbonate, polyoxyethylene sorbitan fatty acid Disintegrants such as esters, sodium lauryl sulfate, stearic acid monoglyceride, starch, crospovidone, povidone, low substituted hydroxypropylcellulose; stearin, cocoa butter, Disintegration inhibitors such as additive oils; Absorption accelerators such as quaternary ammonium salts and sodium lauryl sulfate; Moisturizers such as glycerin; Adsorbents such as starch, lactose, kaolin, bentonite, colloidal silicic acid; Purified talc, stearin Lubricants such as acid salts, boric acid powder and polyethylene glycol can be used. In addition to the above, the tablet of the present invention includes, for example, a surfactant, an absorption accelerator, an adsorbent, a filler, a preservative, a stabilizer, an emulsifier, a solubilizer, and a salt that adjusts osmotic pressure. Can be contained. Furthermore, in addition to the above, the tablet of the present invention may contain other active ingredients such as amino acids, vitamins, and organic acid salts. Examples of other active ingredients include valine, leucine, isoleucine, threonine, methionine, phenylalanine, tryptophan, lysine, glycine, alanine, asparagine, glutamine, serine, cysteine, cystine, tyrosine, proline, hydroxyproline, aspartic acid, glutamic acid , Amino acids such as hydroxylysine, arginine, ornithine, histidine; vitamins such as vitamin A1, vitamin A2, carotene, lycopene (provitamin A), vitamin B6, vitamin B1, vitamin B2, ascorbic acid, nicotinamide, biotin; Examples include alkali metal salts such as sodium chloride and potassium chloride, and organic acid salts such as citrate, acetate and phosphate.
さらに錠剤は、必要に応じ通常の剤皮を施した錠剤、例えば糖衣錠、ゼラチン被包錠、腸溶被錠、フィルムコーティング錠あるいは二重錠、多層錠とすることができる。
(6)錠剤の製造方法
本発明の錠剤の製造方法は、得られた錠剤が所望の効果を発揮できる限り特に限定されず、従来公知の方法に従い製造することができる。また、植物加工物およびパンテチン類の具体的な材料およびそれらの配合割合等は、前述の記載に従って適宜設定される。
Further, the tablets can be made into tablets with ordinary coatings as necessary, for example, sugar-coated tablets, gelatin-encapsulated tablets, enteric-coated tablets, film-coated tablets, double tablets, and multilayer tablets.
(6) Manufacturing method of tablet The manufacturing method of the tablet of this invention is not specifically limited as long as the obtained tablet can exhibit a desired effect, It can manufacture in accordance with a conventionally well-known method. Further, specific materials of plant processed products and panthetins, their blending ratios, and the like are appropriately set according to the above description.
通常は、植物加工物とパンテチン類、およびその他、必要に応じて賦形剤等を混合して打錠すればよい。また、打錠については配合材料の全部を直接打錠してもよく、また打錠前に配合材料の一部または全部を顆粒状にしてそののちに打錠するなど、常法に従い打錠すればよい。
(7)錠剤の硬度および崩壊性
本発明の錠剤の硬度は、本発明の効果を奏する限り特に限定されないが、例えば、垂直方向の硬度が好ましくは6N以上、より好ましくは8N以上、さらに好ましくは10N以上である。本発明において錠剤の硬度は、木屋式デジタル硬度計KHT−20N型(株式会社藤原製作所)を用いて測定される。
Usually, the processed plant product, panthetins, and other excipients or the like may be mixed as necessary, and tableted. For tableting, all of the compounding material may be directly compressed, or part or all of the compounding material may be granulated before tableting and then tableted according to conventional methods. Good.
(7) Tablet hardness and disintegration The hardness of the tablet of the present invention is not particularly limited as long as the effects of the present invention are exhibited. For example, the hardness in the vertical direction is preferably 6 N or more, more preferably 8 N or more, and still more preferably. 10N or more. In the present invention, the hardness of the tablet is measured using a Kiya type digital hardness meter KHT-20N type (Fujiwara Manufacturing Co., Ltd.).
本発明の錠剤の崩壊性は、製造される錠剤の大きさ、形状、製錠時の圧力等により左右されるためこれらに応じて変更し得るので、本発明の効果を奏する限りとくに限定されないが、植物加工物単独からなる錠剤の崩壊時間(T0)に対する、植物加工物およびパンテチン類からなる錠剤の崩壊時間(TX)の割合の逆数、すなわち(T0/TX)にて評価される。 The disintegration property of the tablet of the present invention is not particularly limited as long as the effect of the present invention can be obtained because it can be changed according to the size, shape, pressure at the time of tableting, etc. The reversal of the ratio of the disintegration time (T X ) of the tablet made of plant processed products and panthetins to the disintegration time (T 0 ) of the tablet consisting of the processed plant product alone, ie, (T 0 / T X ) The
例えば、本発明の一実施形態について説明すると、植物加工物として、ダイオウ、カンゾウ、マオウ、シャクヤク、オウゴンおよび/またはショウキョウのエキス末を使用し、圧力25Mpaにて直径9mmの凸型錠剤を打錠して錠剤を製造する場合、崩壊性の向上(崩壊時間の短縮)はとくに限定されないが、好ましくは5%以上、より好ましくは8%以上、さらに好ましくは10%以上である。 For example, an embodiment of the present invention will be described. As a processed plant product, a powdered extract of diam, licorice, mao, peony, ogon and / or ginger is used, and a convex tablet having a diameter of 9 mm is punched at a pressure of 25 Mpa. In the case of producing a tablet by tableting, improvement in disintegration (reduction of disintegration time) is not particularly limited, but it is preferably 5% or more, more preferably 8% or more, and further preferably 10% or more.
錠剤の崩壊時間は、日本薬局方に記載の崩壊時間の測定法によって測定できるが、その他に適宜試験条件を設定し、水溶液中にて錠剤が崩壊する時間を測定すればよく、例えば、100mlビーカーに37℃の水約80ccをいれ、2cmのスターラーバーを400rpmにて回転させ、錠剤を投入してから錠剤が目視により観察できなくなるまでの時間を測定することでも可能である。 The disintegration time of the tablet can be measured by the disintegration time measurement method described in the Japanese Pharmacopoeia. However, other test conditions may be set as appropriate, and the disintegration time in the aqueous solution may be measured. For example, a 100 ml beaker It is also possible to add about 80 cc of water at 37 ° C., rotate a 2 cm stirrer bar at 400 rpm, and measure the time from when the tablet is inserted until the tablet cannot be visually observed.
錠剤の吸湿性は、得られた錠剤を室温25度、湿度50%にて、無包装にて24時間放置した後の錠剤の吸湿性(べたつきの程度)を観察することで評価できる。 The hygroscopicity of the tablet can be evaluated by observing the hygroscopicity (stickiness) of the tablet after leaving the obtained tablet at room temperature of 25 ° C. and humidity of 50% for 24 hours without packaging.
本発明の錠剤の1日摂取量は、摂取対象に応じて適宜変更され得るが、例えば大人一人(体重60kg)に対する1日あたりの投与量は、植物加工物の乾燥重量換算で通常0.01〜12g程度、好ましくは0.05〜10g程度、より好ましくは0.07〜8g程度である。また、例えば植物加工物としてダイオウのエキス末を用いる場合は、総乾燥重量に換算して通常0.1〜10g程度、好ましくは1.0〜8g程度、より好ましくは1.5〜6g程度である。また、本発明の医薬組成物は、通常一日2〜3回に分けて経口投与の形態で用いられる。服用時刻は、特に限定されないが、食前または食間が好ましい。
(8)硬度向上剤、崩壊性向上剤
本発明の錠剤の硬度向上剤は、パンテチン、パンテチンの塩、パントテン酸、パントテン酸の塩、パンテテインおよびパンテノールから選択される少なくとも1種のパンテチン類を有効成分とするものであり、植物加工物を含有する錠剤の硬度を高めることができる。パンテチン類および植物加工物の具体的な材料およびそれらの配合割合等は、前述の記載に従って適宜設定される。また、当該向上剤は、上記錠剤の製造方法に従い打錠することにより製造される。
The daily intake of the tablet of the present invention can be appropriately changed according to the intake subject. For example, the daily dose for one adult (body weight 60 kg) is usually 0.01 in terms of the dry weight of the processed plant product. About 12 g, preferably about 0.05 to 10 g, more preferably about 0.07 to 8 g. Moreover, for example, when using the extract powder of daiou as a processed plant product, it is usually about 0.1 to 10 g, preferably about 1.0 to 8 g, more preferably about 1.5 to 6 g in terms of the total dry weight. is there. The pharmaceutical composition of the present invention is usually used in the form of oral administration divided into 2 to 3 times a day. The dose time is not particularly limited, but is preferably before or between meals.
(8) Hardness improver, disintegration improver The tablet hardness improver of the present invention comprises at least one pantethine selected from pantethine, pantethine salt, pantothenic acid, pantothenic acid salt, pantethein and panthenol. It is an active ingredient and can increase the hardness of a tablet containing a processed plant product. Specific materials of panthetins and processed plant products, their blending ratios, and the like are appropriately set according to the above description. Moreover, the said improvement agent is manufactured by tableting according to the manufacturing method of the said tablet.
また、本発明の錠剤の崩壊性向上剤は、パンテチン、パンテチンの塩、パントテン酸、パントテン酸の塩、パンテテインおよびパンテノールから選択される少なくとも1種のパンテチン類を有効成分とするものであり、植物加工物を含有する錠剤の崩壊時間を短縮することができる。パンテチン類および植物加工物の具体的な材料およびそれらの配合割合等は、前述の記載に従って適宜設定される。また、当該向上剤は、上記錠剤の製造方法に従い打錠することにより製造される。 The tablet disintegration improver of the present invention comprises pantethine, pantethine salt, pantothenic acid, pantothenic acid salt, pantethein and panthenol as an active ingredient. The disintegration time of tablets containing processed plant products can be shortened. Specific materials of panthetins and processed plant products, their blending ratios, and the like are appropriately set according to the above description. Moreover, the said improvement agent is manufactured by tableting according to the manufacturing method of the said tablet.
また、本発明の錠剤の硬度及び崩壊性向上剤は、パンテチン、パンテチンの塩、パントテン酸、パントテン酸の塩、パンテテインおよびパンテノールから選択される少なくとも1種のパンテチン類を有効成分とするものであり、植物加工物を含有する錠剤の硬度を高めることができ、かつ崩壊時間を短縮することができる。パンテチン類および植物加工物の具体的な材料およびそれらの配合割合等は、前述の記載に従って適宜設定される。また、当該向上剤は、上記錠剤の製造方法に従い打錠することにより製造される。
(9)硬度向上方法、崩壊性向上方法
本発明の錠剤の硬度向上方法によれば、植物加工物と、パンテチン、パンテチンの塩、パントテン酸、パントテン酸の塩、パンテテインおよびパンテノールから選択される少なくとも1種のパンテチン類とを併用することにより、植物加工物を含有する錠剤の硬度を高めることができる。パンテチン類および植物加工物の具体的な材料およびそれらの配合割合等は、前述の記載に従って適宜設定される。また、当該向上剤は、上記錠剤の製造方法に従い打錠することにより製造される。
The tablet hardness and disintegration improver of the present invention comprises at least one panthetin selected from pantethine, pantethine salt, pantothenic acid, pantothenic acid salt, pantethein and panthenol as an active ingredient. Yes, the hardness of the tablet containing the processed plant product can be increased, and the disintegration time can be shortened. Specific materials of panthetins and processed plant products, their blending ratios, and the like are appropriately set according to the above description. Moreover, the said improvement agent is manufactured by tableting according to the manufacturing method of the said tablet.
(9) Hardness improvement method, disintegration improvement method According to the hardness improvement method of the tablet of the present invention, it is selected from plant processed products, pantethine, pantethine salt, pantothenic acid, pantothenic acid salt, pantethein and panthenol By using together with at least 1 sort of panthetin, the hardness of the tablet containing a plant processed material can be raised. Specific materials of panthetins and processed plant products, their blending ratios, and the like are appropriately set according to the above description. Moreover, the said improvement agent is manufactured by tableting according to the manufacturing method of the said tablet.
本発明の錠剤の崩壊性向上方法によれば、植物加工物と、パンテチン、パンテチンの塩、パントテン酸、パントテン酸の塩、パンテテインおよびパンテノールから選択される少なくとも1種のパンテチン類とを併用することにより、植物加工物を含有する錠剤の崩壊時間を短縮することができる。パンテチン類および植物加工物の具体的な材料およびそれらの配合割合等は、前述の記載に従って適宜設定される。また、当該向上剤は、上記錠剤の製造方法に従い打錠することにより製造される。 According to the method for improving disintegration of a tablet of the present invention, a processed plant product and pantethine, pantethine salt, pantothenic acid, pantothenic acid salt, pantethein and panthenol are used in combination. Thus, the disintegration time of the tablet containing the processed plant product can be shortened. Specific materials of panthetins and processed plant products, their blending ratios, and the like are appropriately set according to the above description. Moreover, the said improvement agent is manufactured by tableting according to the manufacturing method of the said tablet.
本発明の錠剤の硬度および崩壊性向上方法によれば、植物加工物と、パンテチン、パンテチンの塩、パントテン酸、パントテン酸の塩、パンテテインおよびパンテノールから選択される少なくとも1種のパンテチン類とを併用することにより、植物加工物を含有する錠剤の硬度を高めることができ、かつ崩壊時間を短縮することができる。パンテチン類および植物加工物の具体的な材料およびそれらの配合割合等は、前述の記載に従って適宜設定される。また、当該向上剤は、上記錠剤の製造方法に従い打錠することにより製造される。 According to the tablet hardness and disintegration improving method of the present invention, a plant processed product and at least one panthetin selected from pantethine, pantethine salt, pantothenic acid, pantothenic acid salt, pantethein and panthenol By using together, the hardness of the tablet containing a processed plant product can be increased, and the disintegration time can be shortened. Specific materials of panthetins and processed plant products, their blending ratios, and the like are appropriately set according to the above description. Moreover, the said improvement agent is manufactured by tableting according to the manufacturing method of the said tablet.
本発明によれば、パンテチンに代えてマルチトール、マンニトールおよびソルビトールのような従来結合剤として使用されている物質を植物加工物と併用した場合より、優れた硬度を錠剤に付与することができる。また、本発明によれば、植物加工物を含有する錠剤、さらには植物加工物以外の物質を含有する錠剤においても、硬度および/または崩壊時間を短縮させることができる。 According to the present invention, it is possible to impart superior hardness to tablets compared to the case where substances conventionally used as binders such as maltitol, mannitol and sorbitol are used in combination with plant processed products instead of pantethine. In addition, according to the present invention, hardness and / or disintegration time can be shortened even in a tablet containing a processed plant product, and further in a tablet containing a substance other than the processed plant product.
以下に実施例、処方例等を示して本発明をより詳細に説明するが、本発明はこれらに限定されない。
実施例1
植物加工物として「ダイオウエキス末」(三國株式会社製)を、パンテチン類としては80重量%パンテチン水溶液である「パンテチンA」(第一ファインケミカル株式会社製)を用いて、下記表1の配合割合にて混合した。表中の配合割合は、ダイオウエキス末については乾燥重量、パンテチンについては、パンテチンAのパンテチン含有率(80重量%)からそれぞれ算出した値である。得られた混合物0.36gを油圧打錠機SMP−3(理研精機株式会社製)を用いて圧力25Mpaにて直径9mmの凸型錠剤を打錠して錠剤を得た。この打錠時に杵や臼への錠剤の付着の有無を確認した。
Hereinafter, the present invention will be described in more detail with reference to examples and formulation examples, but the present invention is not limited thereto.
Example 1
Using “Daiou extract powder” (manufactured by Mikuni Co., Ltd.) as a processed plant product, and “pantetin A” (manufactured by Daiichi Fine Chemical Co., Ltd.) which is an 80 wt% pantetin aqueous solution as pantetins, And mixed. The blending ratios in the table are the values calculated from the dry weight for Diou extract powder and the pantethine content (80% by weight) of pantethine A for pantethine, respectively. Using 0.36 g of the obtained mixture, a 9-diameter convex tablet was tableted using a hydraulic tableting machine SMP-3 (manufactured by Riken Seiki Co., Ltd.) at a pressure of 25 Mpa to obtain a tablet. At the time of tableting, it was confirmed whether or not the tablets adhered to the punch or mortar.
得られた錠剤について、木屋式デジタル硬度計KHT−20N型(株式会社藤原製作所製)を用いて錠剤に対して垂直方向の硬度を測定した。垂直方向は、打錠時に杵で加圧・圧縮する方向であり、水平方向は、垂直方向に対して直角の方向である。 About the obtained tablet, the hardness of the perpendicular | vertical direction was measured with respect to the tablet using the Kiya-type digital hardness meter KHT-20N type (made by Fujiwara Seisakusyo Co., Ltd.). The vertical direction is the direction of pressing and compressing with a scissors during tableting, and the horizontal direction is the direction perpendicular to the vertical direction.
また、得られた錠剤について崩壊時間を測定し、崩壊性の評価を防風通聖散単独からなる錠剤と比較して行った。さらに、得られた錠剤の吸湿性について観察した。各処方10錠の平均値の結果を表1に記した。
(崩壊時間の測定)
100mlビーカーに37℃の水約80ccをいれ、2cmのスターラーバーを400rpmにて回転させ、錠剤を投入してから錠剤が目視により観察できなくなるまでの時間を測定した。
Moreover, disintegration time was measured about the obtained tablet, and disintegration evaluation was performed compared with the tablet which consists of a wind-proof tsuyosan alone. Furthermore, the hygroscopicity of the obtained tablets was observed. The results of the average value of 10 tablets for each formulation are shown in Table 1.
(Measurement of disintegration time)
About 80 cc of 37 ° C. water was put into a 100 ml beaker, a 2 cm stirrer bar was rotated at 400 rpm, and the time from when the tablet was introduced until the tablet could no longer be observed visually was measured.
(崩壊性の評価)
防風通聖散単独からなる錠剤の崩壊時間(T0)に対する、防風通聖散およびパンテチン類からなる錠剤の崩壊時間(TX)の割合の逆数、すなわち(T0/TX)を算出して評価した。
(Evaluation of disintegration)
Calculate the reciprocal of the ratio of the disintegration time (T X ) of Fengtsu Sanseiki and the pantetins to the disintegration time (T 0 ) of the tablet consisting of Fengtsu Sanseong alone, that is, (T 0 / T X ) And evaluated.
(吸湿性の評価)
得られた錠剤を室温25度、湿度50%にて、無包装にて24時間放置した後の錠剤の吸湿性を観察した。錠剤表面のべたつきが明らかに認められた場合を「×」、わずかにべたつく場合を「△」、べたつきが認められなかった場合を「○」として判定した。
(Hygroscopic evaluation)
The tablets obtained were allowed to stand for 24 hours without packaging at room temperature of 25 ° C. and humidity of 50%, and the hygroscopicity of the tablets was observed. The case where the stickiness on the tablet surface was clearly recognized was judged as “×”, the case where it was slightly sticky was judged as “Δ”, and the case where stickiness was not found was judged as “◯”.
表1から明らかなように、ダイオウエキス末にパンテチンを加えることにより、硬度の増加と、パンテチン類の添加濃度依存的な崩壊時間の短縮が観られた。ダイオウエキス末100重量部に対するパンテチン類の総量が0.1重量部である場合、パンテチン類を含有しない錠剤と比較して、錠剤強度は格段に向上した。さらに、ダイオウエキス末100重量部に対するパンテチン類の総量が1.0重量部である場合には、前者よりさらに錠剤強度が向上した。一方、ダイオウエキス末100重量部に対するパンテチン類の総量が20重量部である場合、吸湿性は好ましくなかった。
実施例2
実施例1において、パンテチン類として50重量%のパンテチン細粒「パントシン(登録商標)散50%」(第一三共株式会社)を用い、下記表2の配合割合で混合した以外は、上記実施例1と同様にして錠剤を製造し、硬度および崩壊時間を測定し、打錠時の杵や臼への付着の有無、吸湿性を観察した。なお、パンテチンの配合割合は細粒中のパンテチン含有率(50重量%)から算出した値である。各処方10錠の平均値の結果を表2に記した。
As is clear from Table 1, by adding pantethine to the powdered diao extract, an increase in hardness and a shortening of the disintegration time depending on the addition concentration of panthetins were observed. When the total amount of panthetins relative to 100 parts by weight of the daiou extract powder is 0.1 parts by weight, the tablet strength is markedly improved compared to tablets that do not contain pantetins. Furthermore, when the total amount of pantethines was 100 parts by weight with respect to 100 parts by weight of the diau extract powder, the tablet strength was further improved from the former. On the other hand, when the total amount of panthetins was 20 parts by weight with respect to 100 parts by weight of the diau extract powder, the hygroscopicity was not preferable.
Example 2
In Example 1, 50% by weight of pantethine fine granule “Pantosine (registered trademark) powder 50%” (Daiichi Sankyo Co., Ltd.) was used as the panthetin, and the mixture was mixed at the blending ratio shown in Table 2 below. Tablets were produced in the same manner as in Example 1, the hardness and disintegration time were measured, and the presence or absence of adhesion to the pestle or die during tableting and the hygroscopicity were observed. In addition, the compounding ratio of pantethine is a value calculated from the pantethine content (50% by weight) in the fine granules. The results of the average value of each tablet of 10 tablets are shown in Table 2.
表2から明らかなように、上記パンテチンの細粒を使用した場合も、前記実施例1と同様に硬度の増加と、パンテチン類の添加濃度依存的な崩壊時間の短縮が観られた。
実施例3
実施例1において、植物加工物として「カンゾウエキス末」、「マオウエキス末」、「シャクヤクエキス末」、「オウゴンエキス末」または「ショウキョウエキス末」(いずれも三國株式会社製)を、パンテチン類として「パンテチンA」または「パントシン散50%」を用いた以外は、実施例1と同様に錠剤を得た。結果としては前記実施例1と同様に硬度の増加と、パンテチン類の添加濃度依存的な崩壊時間の短縮が観られた。
実施例4および5
実施例1または2において、植物加工物として、ダイオウ1.5(重量部、以下同じ)、カンゾウ2.0を、水20倍量を用いて約100℃で1時間抽出し、遠心分離して抽出液を得、減圧下で濃縮してスプレードライを用いて乾燥した「植物抽出エキス末A」(スプレードライヤーによる乾燥は、抽出液を回転数10000rpmのアトマイザーに落下させ、150℃の空気の熱風を供給して行った)を用いた以外は、実施例1または2と同様に錠剤を得た。それぞれ実施例4、5とする。各処方10錠の平均値の結果を、それぞれ表3および4に記した。
As is apparent from Table 2, even when the pantethine fine granules were used, an increase in hardness and a reduction in disintegration time depending on the addition concentration of panthetins were observed as in Example 1.
Example 3
In Example 1, as a processed plant product, “licorice extract powder”, “mao extract powder”, “peony extract powder”, “ogon extract powder” or “falcon extract powder” (all manufactured by Mikuni Co., Ltd.) A tablet was obtained in the same manner as in Example 1 except that “Panthetine A” or “Pantosine powder 50%” was used. As a result, as in the case of Example 1, an increase in hardness and a shortening of the disintegration time depending on the addition concentration of panthetins were observed.
Examples 4 and 5
In Example 1 or 2, Daio 1.5 (parts by weight, the same applies hereinafter) and licorice 2.0 were extracted as processed plant products using 20 times the amount of water at about 100 ° C. for 1 hour and centrifuged. Obtained extract, concentrated under reduced pressure and dried using spray drying “Plant Extract Extract Powder A” (drying with a spray dryer drops the extract onto an atomizer with a rotational speed of 10000 rpm, hot air of 150 ° C. air Were used in the same manner as in Example 1 or 2, except that the above was used. The examples are referred to as Examples 4 and 5, respectively. The results of the average value of 10 tablets for each formulation are shown in Tables 3 and 4, respectively.
表3および4から明らかなように、「植物抽出エキス末A」を使用した場合も、前記実施例1〜3と同様に硬度の増加と、パンテチン類の添加濃度依存的な崩壊時間の短縮が観られた。
実施例6および7
実施例1または2において、植物加工物として、トウキ1.2(重量部、以下同じ)、シャクヤク1.2、センキュウ1.2、サンシシ1.2、レンギョウ1.2、ハッカ1.2、ショウキョウ1.2、ケイガイ1.2、ボウフウ1.2、マオウ1.2、ダイオウ1.5、ボウショウ1.5、ビャクジュツ2.0、キキョウ2.0、オウゴン2.0、カンゾウ2.0、セッコウ2.0およびカッセキ3.0を、水20倍量を用いて約100℃で1時間抽出し、遠心分離して抽出液を得、減圧下で濃縮してスプレードライを用いて乾燥した「植物抽出エキス末B」(スプレードライヤーによる乾燥は、抽出液を回転数10000rpmのアトマイザーに落下させ、150℃の空気の熱風を供給して行った)を用いた以外は、実施例1または2と同様に錠剤を得た。それぞれ実施例6、7とする。各処方10錠の平均値の結果を、それぞれ表5および6に記した。
As is apparent from Tables 3 and 4, even when “plant extract powder A” is used, the increase in hardness and the shortening of the disintegration time dependent on the addition concentration of panthetins can be achieved as in Examples 1-3. It was watched.
Examples 6 and 7
In Example 1 or 2, as processed plant products, Toki 1.2 (parts by weight, the same applies hereinafter), Peonies 1.2, Senkyu 1.2, Sanshi 1.2, Forsythia 1.2, Hakka 1.2, Show Kyo 1.2, Kei-Gai 1.2, Bow-Fu 1.2, Maou 1.2, Dai-Oo 1.5, Bow-Sho 1.5, Sandalwood 2.0, Kyo-Jo 2.0, Ogon 2.0, Licorice 2.0, Gypsum 2.0 and Kasseki 3.0 were extracted with 20 times the amount of water at about 100 ° C. for 1 hour, centrifuged to obtain an extract, concentrated under reduced pressure, and dried using spray drying. Example 1 or 2 except that the plant extract powder B "(drying with a spray dryer was performed by dropping the extract into an atomizer with a rotational speed of 10000 rpm and supplying hot air at 150 ° C.) same A tablet was obtained. The examples are referred to as Examples 6 and 7, respectively. The results of the average value of 10 tablets for each formulation are shown in Tables 5 and 6, respectively.
表5および6から明らかなように、「植物抽出エキス末B」を使用した場合も、前記実施例1〜5と同様に硬度の増加と、パンテチン類の添加濃度依存的な崩壊時間の短縮が観られた。
実施例8
実施例1または2において、植物加工物としてプランタゴオバタ、朝鮮人参、田七人参、西洋人参またはカンカを用いた以外は、実施例1または2と同様に錠剤を得た。各々の植物加工物は、水20倍量を用いて約100℃で1時間抽出し、遠心分離して抽出液を得、減圧下で濃縮してスプレードライを用いて乾燥させることにより得た。スプレードライヤーによる乾燥は、抽出液を回転数10000rpmのアトマイザーに落下させ、150℃の空気の熱風を供給して行った。朝鮮人参を用いた場合の、各処方10錠の平均値の結果を表7および8に記した。
As is clear from Tables 5 and 6, even when “plant extract powder B” was used, the increase in hardness and the shortening of the disintegration time dependent on the addition concentration of panthetins were achieved as in Examples 1-5. It was watched.
Example 8
In Example 1 or 2, tablets were obtained in the same manner as in Example 1 or 2 except that Plantagogobata, Ginseng, Panax ginseng, Western ginseng or Kanka were used as plant processed products. Each processed plant product was obtained by extracting at about 100 ° C. for 1 hour using 20 times the amount of water, centrifuging to obtain an extract, concentrating under reduced pressure, and drying using spray drying. Drying with a spray dryer was performed by dropping the extract into an atomizer with a rotational speed of 10,000 rpm and supplying hot air of 150 ° C. air. Tables 7 and 8 show the average results of 10 tablets for each prescription when using ginseng.
表7および8から明らかなように、朝鮮人参を使用した場合も、前記実施例1と同様に硬度の増加と、パンテチン類の添加濃度依存的な崩壊時間の短縮が観られたが、硬度については、実施例1〜7の方が高かった。プランタゴオバタ、田七人参、西洋人参またはカンカを使用した場合も、朝鮮人参と同様な傾向が観られた。
比較例1〜3
前記実施例1において、パンテチンに代えてマルチトール(東和化成工業株式会社製「レシス」:比較例1)、マンニトール(三栄源エフ・エフ・アイ株式会社製「マンニトール」:比較例2)またはソルビトール(ソルビトール(三栄源エフ・エフ・アイ株式会社製):比較例3)を使用し、下記表9〜11の配合割合で混合した以外は、上記実施例1と同様に錠剤を得た。マルチトール、マンニトールおよびソルビトールは通常結合剤として使用されるものである。各処方10錠の平均値の結果を、表9〜11に記した。
As is clear from Tables 7 and 8, when ginseng was used, an increase in hardness was observed as in Example 1 and a decrease in disintegration time depending on the addition concentration of panthetins was observed. Were higher in Examples 1-7. The same tendency as for ginseng was observed when plantagogobata, seven ginseng, western ginseng or kanka were used.
Comparative Examples 1-3
In Example 1, instead of pantethine, maltitol (“Resis” manufactured by Towa Kasei Kogyo Co., Ltd .: Comparative Example 1), mannitol (“Mannitol” manufactured by Saneigen FFI Co., Ltd .: Comparative Example 2) or sorbitol (Sorbitol (manufactured by San-Ei Gen FFI Co., Ltd.): Comparative Example 3) was used, and tablets were obtained in the same manner as in Example 1 except that they were mixed at the blending ratios shown in Tables 9 to 11 below. Maltitol, mannitol and sorbitol are usually used as binders. The result of the average value of 10 tablets of each prescription is shown in Tables 9-11.
表9〜11から明らかなように、結合剤として一般的に使用されるマルチトール、マンニトールまたはソルビトールを加えた場合は、望まれるほどの硬度の増加は観られなかった。
処方例1〜30
処方例1〜30に従い、常法により錠剤を製した。
As is apparent from Tables 9-11, the desired increase in hardness was not observed when maltitol, mannitol or sorbitol, which are commonly used as binders, were added.
Formulation Examples 1-3
According to prescription examples 1 to 30, tablets were produced by a conventional method.
Claims (5)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008015688A JP5224834B2 (en) | 2008-01-25 | 2008-01-25 | Tablets containing processed plant products and panthetins |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2008015688A JP5224834B2 (en) | 2008-01-25 | 2008-01-25 | Tablets containing processed plant products and panthetins |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2009173604A JP2009173604A (en) | 2009-08-06 |
JP5224834B2 true JP5224834B2 (en) | 2013-07-03 |
Family
ID=41029103
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2008015688A Active JP5224834B2 (en) | 2008-01-25 | 2008-01-25 | Tablets containing processed plant products and panthetins |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5224834B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102573871B (en) * | 2009-09-01 | 2015-05-20 | 统欣生物科技股份有限公司 | Antiphlogistic, antioncotic and analgesic chinese herbal composition,preparative method and usage thereof |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3319625B2 (en) * | 1993-05-12 | 2002-09-03 | ホーユー株式会社 | Fast-disintegrating crude drug formulation |
JP2001000142A (en) * | 1999-06-23 | 2001-01-09 | Artnature Co Ltd | Nutritive assistance food for hair restoration and hair growth |
JP2006016356A (en) * | 2004-07-02 | 2006-01-19 | Dai Ichi Seiyaku Co Ltd | Composition for hypercholesterolemia |
JP2006290782A (en) * | 2005-04-08 | 2006-10-26 | Tokiwa Yakuhin Kogyo Kk | Antiedemic composition |
JP2006290802A (en) * | 2005-04-11 | 2006-10-26 | Kanebo Cosmetics Inc | New diagnostic method for constitution and counseling method using the diagnosis |
JP5286662B2 (en) * | 2005-11-15 | 2013-09-11 | 大正製薬株式会社 | Annakasan-containing tablets |
JP5344289B2 (en) * | 2006-06-29 | 2013-11-20 | 株式会社ツムラ | Kampo extract-containing tablet composition |
-
2008
- 2008-01-25 JP JP2008015688A patent/JP5224834B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
JP2009173604A (en) | 2009-08-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI556823B (en) | Orally disintegrating tablet containing acarbose | |
JP4689468B2 (en) | Tablet and production method thereof | |
JP7194951B2 (en) | Dry granules, solid preparations containing the dry granules, and methods for producing them | |
CN102451162A (en) | Olanzapine medicine absorbed through oral mucosa | |
JP5328166B2 (en) | Tablets containing herbal medicine and panthetins | |
JP5224834B2 (en) | Tablets containing processed plant products and panthetins | |
JP2008297283A (en) | Composition having antioxidant activity | |
JP6407545B2 (en) | Pharmaceutical composition | |
WO2009093737A1 (en) | Anti-obesity pharmaceutical composition | |
JP6195428B2 (en) | Granulated product containing Kamitsumonoyu extract powder | |
JP5989960B2 (en) | Salacia-containing composition | |
WO2006090640A1 (en) | Tablet composition containing amino acid and process for producing tablet | |
JP6272432B2 (en) | Granulated product containing Kamitsumonoyu extract powder | |
CA2492156C (en) | Tablet composition containing kampo medicinal extract and its manufacturing process | |
JP2009242354A (en) | Pharmaceutical formulation | |
JP5467787B2 (en) | Oral solid composition | |
JP7296198B2 (en) | Pharmaceutical composition | |
JP5339761B2 (en) | Foutsutsu Seisaku formulation | |
JP7133982B2 (en) | tablet composition | |
JP5610670B2 (en) | Foutsutsu Seisaku formulation | |
JP7158831B2 (en) | Tablet containing goshitsu processed material | |
JP2018131451A (en) | Pharmaceutical composition | |
JP4630614B2 (en) | Fast disintegrating solid preparation | |
JP2023041807A (en) | Solid pharmaceutical composition and method for producing the same | |
US20210252093A1 (en) | Pharmaceutical composition containing acetone-extracted product from gamboge resin, and formulation manufactured from such composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20110104 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20121204 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130201 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130219 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130312 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5224834 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160322 Year of fee payment: 3 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |